Table 4.
Drug resistance profiles in patients with different treatment regimens.
| Types | Drug | Treatment Regimens | Total | |||
|---|---|---|---|---|---|---|
| 2NRTIs+NNRTIs | 2NRTIs+PIs | 2NRTIs+INSTIs | Others | |||
| NRTIs | ABC | 38 | 20 | 1 | 6 | 65 |
| AZT | 4 | 1 | 0 | 2 | 7 | |
| D4T | 16 | 7 | 0 | 2 | 25 | |
| DDI | 20 | 10 | 0 | 3 | 33 | |
| FTC | 38 | 20 | 1 | 5 | 64 | |
| 3TC | 38 | 20 | 1 | 5 | 64 | |
| TDF | 14 | 7 | 0 | 2 | 23 | |
| DR cases | 39 | 20 | 1 | 6 | ||
| NNRTIs | DOR | 31 | 17 | 2 | 5 | 55 |
| EFV | 49 | 25 | 4 | 8 | 86 | |
| ETR | 21 | 13 | 0 | 2 | 36 | |
| NVP | 49 | 25 | 4 | 8 | 86 | |
| RPV | 28 | 16 | 2 | 4 | 50 | |
| DR cases | 49 | 25 | 4 | 8 | ||
| PIs | ATV | 0 | 0 | 2 | 0 | 2 |
| DRV | 0 | 0 | 1 | 0 | 1 | |
| FPV | 1 | 0 | 3 | 0 | 4 | |
| IDV | 2 | 0 | 3 | 0 | 5 | |
| LPV | 1 | 0 | 3 | 0 | 4 | |
| NFV | 7 | 1 | 3 | 1 | 12 | |
| SQV | 1 | 0 | 2 | 0 | 3 | |
| TPV | 3 | 0 | 1 | 0 | 4 | |
| DR cases | 9 | 3 | 1 | 1 | ||
ABC, Abacavir; AZT, Zidovudine; D4T, Stavudine; DDI, Didanosine: FTC, Emtricitabine; 3TC, Lamivudine; TDF, Tenofovir; DOR, Doravirine; EFV, Efavirenz; ETR, Etravirine; NVP, Nevirapine; RPV, Rilpivirine; ATV, Atazanavir; DRV, Darunavir; FPV, Fosamprenavir; IDV, Indinavir; LPV, Lopinavir; NFV, Nelfinavir; SQV, Saquinavir; TPV, Tipranavir.